PSMA PET/CT was positive in 68% of ccRCC patients, with a mean SUVmax of 34.1; had a moderate uptake in one papillary cancer (SUVmax 10.2 in target lesion of iliac bone) and was negative in the other; and had a weak signal in a chromophobe cancer (SUVmax 5.5). The gene discussed is FOLH1; the disease is nonpapillary renal cell carcinoma.